HS
BMY icon

HighVista Strategies’s Bristol-Myers Squibb BMY Stock Holding History

HighVista Strategies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,100
Closed -$374K – 177
2017
Q4 		$374K Sell
6,100
-1,900
-24% -$119K 0.1% 148
2017
Q3 		$510K Buy
+8,000
New +$467K 0.12% 124

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighVista Strategies's BMY Position: Q1 2018 in Review

HighVista Strategies sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 6,100 shares — an estimated $374K sold.

HighVista Strategies first reported a position in BMY in Q3 2017 and held it in 2 quarters. The position peaked at $510K in Q3 2017. 1,746 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • HighVista Strategies reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
  • HighVista Strategies sold 6,100 Bristol-Myers Squibb shares in Q1 2018, an estimated $374K.
  • HighVista Strategies first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 2 quarters.
  • HighVista Strategies's Bristol-Myers Squibb position peaked at $510K in Q3 2017.
  • 1,746 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on HighVista Strategies's 13F filing for Q1 2018, filed 15 May 2018.